A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8).
Pozzilli P, Crinò A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N, Corbi S, Spera S, Suraci C, Cervoni M, Matteoli MC, Patera IP, Ghirlanda G; IMDIAB Group.
Pozzilli P, et al. Among authors: manfrini s.
Diabetes Technol Ther. 2003;5(6):965-74. doi: 10.1089/152091503322641006.
Diabetes Technol Ther. 2003.
PMID: 14709198
Clinical Trial.